Brief: Vaccinex Announces $1.5 Mln Registered Direct Offering
27/03/2024 12:43
March 27 (Reuters) - Vaccinex Inc VCNX.O :
* VACCINEX, INC. ANNOUNCES $1.5 MILLION REGISTERED DIRECT
OFFERING
AND CONCURRENT PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER
NASDAQ RULES
* ENTERED INTO DEFINITIVE AGREEMENTS WITH CERTAIN
INSTITUTIONAL
INVESTORS FOR PURCHASE AND SALE OF 193,000 SHARES
* OFFERING AT A COMBINED PURCHASE PRICE OF $7.77 PER SHARE
AND
ACCOMPANYING WARRANT
Source text for Eikon: ID:nGNX9gWkwR
Further company coverage: VCNX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vaccinex
See all newsBrief: Vaccinex Reports Third Quarter 2024 Financial Results And Provides Corporate Update
Brief: Vaccinex Says On Oct 7, Got Letter From The Nasdaq Listing Staff Stating That Co Had Not Regained Compliance With The Equity Standard
Brief: VaccinexExercise Of Warrants For $6.2 Million In Gross Proceeds
Brief: Vaccinex Provides Update On New Findings For Signal-Ad Phase 1B/2 Trial Of Pepinemab In Alzheimer’S Disease
Brief: Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease